Losartan Added to β-Blockade Therapy for Aortic Root Dilation in Marfan Syndrome: A Randomized, Open-Label Pilot Study
- 1 March 2013
- journal article
- research article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 88 (3), 271-276
- https://doi.org/10.1016/j.mayocp.2012.11.005
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The revised Ghent nosology for the Marfan syndromeJournal of Medical Genetics, 2010
- Angiotensin II Blockade and Aortic-Root Dilation in Marfan's SyndromeThe New England Journal of Medicine, 2008
- Beta-Blocker Therapy Does Not Alter the Rate of Aortic Root Dilation in Pediatric Patients with Marfan SyndromeThe Journal of Pediatrics, 2007
- The effect of beta-blocker therapy on clinical outcome in patients with Marfan's syndrome: A meta-analysisInternational Journal of Cardiology, 2007
- Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan SyndromeScience, 2006
- Theoretical and empirical derivation of cardiovascular allometric relationships in childrenJournal of Applied Physiology, 2005
- Latent Transforming Growth Factor β-binding Protein 1 Interacts with Fibrillin and Is a Microfibril-associated ProteinJournal of Biological Chemistry, 2003
- Aortic stiffness as a risk factor for recurrent acute coronary events in patients with ischaemic heart diseaseEuropean Heart Journal, 2000
- Two-dimensional echocardiographic aortic root dimensions in normal children and adultsThe American Journal of Cardiology, 1989
- Evaluation of aortic insufficiency by Doppler color flow mappingJournal of the American College of Cardiology, 1987